We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.
Phaeochromocytomas and paragangliomas (PPGLs) release catecholamines leading to catecholamine-induced hypertensive (CIH) crises, with blood pressure greater than or equal to 180/120 mm Hg. CIH crises…
The prevalence of type 2 diabetes, along with related conditions, such as metabolic syndrome and obesity, has increased globally in the past two decades affecting…
Adults with heterozygous familial hypercholesterolaemia in most WHO regions have a higher type 2 diabetes prevalence than in Europe. Obesity markedly increases the risk of…
In most countries, especially in low-income and middle-income countries, diabetes treatment has not increased at all or has not increased sufficiently in comparison with the…
Addressing obesity must be at the heart of the global NCD response if we are to stem the tide of rising NCDs.
In the early 1990s, a pivotal randomised trial sponsored by the National Institute of Neurological Disorders and Stroke (NINDS) showed that intravenous thrombolysis with alteplase…
The global dengue burden in children and adolescents is high and has been increasing from 1990 to 2021, even though the distribution patterns vary across…
👋📣Welcome to the official YouTube channel of the European Association for the Study of Diabetes (EASD)! Founded in 1965, EASD is a non-profit, medical scientific…
According to WHO’s new global dengue surveillance system (launched May, 2024), there have been approximately 13 million reported cases (almost 42,000 of them severe) and…
As the fifth anniversary of the emergence of SARS-CoV-2 approaches in December, 2024, the global landscape is overburdened by recurring epidemics, supply chain disruptions, climate…
